I.D. Systems Appoints Chris Wolfe as New Chief Executive Officer
Dec 08, 2016 14:00 pm UTC| Business
WOODCLIFF LAKE, N.J., Dec. 08, 2016 -- I.D. Systems, Inc. (NASDAQ:IDSY), a leading provider of wireless solutions for the Industrial Internet of Things, has announced that current Chief Product Officer Chris Wolfe has...
Condor Hospitality Trust Declares Fourth Quarter Common Dividend of $0.03 Per Share
Dec 08, 2016 14:00 pm UTC| Business
BETHESDA, Md., Dec. 08, 2016 -- Condor Hospitality Trust, Inc. (NASDAQ:CDOR), a hotel-focused real estate investment trust (REIT) headquartered and incorporated in the state of Maryland, today announced that its Board...
Dec 08, 2016 14:00 pm UTC| Business
NEW YORK, Dec. 08, 2016 -- National General Holdings Corp. (Nasdaq:NGHC) today announced that it has entered into a renewal rights transaction with Nationwide Mutual Insurance Company for its personal and commercial...
The Fight Against Prostate Cancer: What Men Need to Know
Dec 08, 2016 14:00 pm UTC| Business
NEW YORK, Dec. 08, 2016 -- Prostate cancer is the second most common cancer among men, and it is estimated that nearly three million men are living with the disease in the United States. Thankfully, many prostate...
Pinnacle Foods to Host Investor Luncheon and Presentation
Dec 08, 2016 14:00 pm UTC| Business
PARSIPPANY, N.J., Dec. 08, 2016 -- Pinnacle Foods Inc. (NYSE:PF) today announced that it will be hosting an investor luncheon and presentation in New York City on Thursday, December 15, 2016, at 12:00PM ET, during which...
Actua Announces Preliminary Results of Tender Offer
Dec 08, 2016 13:59 pm UTC| Business
RADNOR, Pa., Dec. 08, 2016 -- Actua Corporation(Nasdaq:ACTA) today announced the preliminary results of its modified “Dutch auction” tender offer, which expired at 11:59 p.m., New York City time, on Wednesday, December...
Dec 08, 2016 13:46 pm UTC| Business
-3 patients had confirmed partial responses by RECIST criteria from ongoing Phase I studies with RAD1901 in patients with advanced estrogen receptor positive breast cancer- -In the Phase 1 dose escalation and expansion...